UPDATE: Teva Pharmaceutical Sells 7-Year Euro Bond
29 Mars 2012 - 10:10PM
Dow Jones News
Teva Pharmaceutical Finance, guaranteed by Teva Pharmaceutical
Industries Ltd. (TEVA, TEVA.TV), completed a $1 billion,
euro-denominated sale of seven-year bonds at 100 basis points over
midswaps, said one of the banks running the deal Thursday.
The 100-basis-point spread offered on the 2.875% bonds compares
with initial price guidance set between 115 and 120 basis points
over midswaps.
BNP Paribas S.A., HSBC Holdings PLC, and J.P. Morgan Chase and
Co., are the lead managers one the deal.
The deal has been rated A3 by Moody's Investors Service and A-
by Standard & Poor's.
-By Patrick McGee and Sarka Halas, Dow Jones Newswires;
212-416-2382; patrick.mcgee@dowjones.com